NEW YORK (GenomeWeb) – Spartan Bioscience today announced a sample-to-result device that purports to be the world's smallest PCR-based molecular diagnostics platform.

The Spartan Cube is four inches on each side and enables 30-minute diagnostic tests, CEO Paul Lem told GenomeWeb in an interview. The company also noted that it is smaller than other commercially available point-of-care, sample-to-result systems from Alere and Roche, as well as a proposed device from Cepheid.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.